Announcing our next community AMA 📺💬
Pressing questions for the Triall team?
On January 31 at 13:00 UTC, Triall will host its 11th community AMA on YouTube, answering both live and pre-submitted questions from the Triall community.
🎙 AMA Guests
- Hadil Es-Sbai, Chief Executive Officer
- Niels Klomp, Chief Technology Officer
- Arno Bisschop, Chief Medical Officer
- Raymond van der Waal, Head of Strategic Partnerships
📬 AMA Questions
Submit your questions here: bit.ly/TRLvidAMA11
The 5 best questions get $50 in TRL tokens💰
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1618227801865457664?s=20&t=DOOZ1-N_B7HbAZVkoz3IRg
#blockchainforhealth #TRL
Pressing questions for the Triall team?
On January 31 at 13:00 UTC, Triall will host its 11th community AMA on YouTube, answering both live and pre-submitted questions from the Triall community.
🎙 AMA Guests
- Hadil Es-Sbai, Chief Executive Officer
- Niels Klomp, Chief Technology Officer
- Arno Bisschop, Chief Medical Officer
- Raymond van der Waal, Head of Strategic Partnerships
📬 AMA Questions
Submit your questions here: bit.ly/TRLvidAMA11
The 5 best questions get $50 in TRL tokens💰
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1618227801865457664?s=20&t=DOOZ1-N_B7HbAZVkoz3IRg
#blockchainforhealth #TRL
Fact of the day 🔍
70% of research site staff believe that conducting clinical trials has become much more difficult over the past five years.
The most commonly reported issues include staffing challenges, study budgets, and protocol complexity.
Triall helps promote site convenience and engagement by offering a single point access solution with intuitive tools for data capture and patient management.
Source: https://csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1620029058909077511?s=20&t=MS8hqB9v91c5ZQzvWvIxlQ
#blockchainforhealth #TRL
70% of research site staff believe that conducting clinical trials has become much more difficult over the past five years.
The most commonly reported issues include staffing challenges, study budgets, and protocol complexity.
Triall helps promote site convenience and engagement by offering a single point access solution with intuitive tools for data capture and patient management.
Source: https://csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1620029058909077511?s=20&t=MS8hqB9v91c5ZQzvWvIxlQ
#blockchainforhealth #TRL
New month, new AMA, we’re live once again! 🚨📺💬
Tune in to this month’s live #community #AMA 👇
https://www.youtube.com/watch?v=VZF5RnCDSbk
Tune in to this month’s live #community #AMA 👇
https://www.youtube.com/watch?v=VZF5RnCDSbk
YouTube
Triall community AMA #11
In the Triall community AMA, members of the core Triall team answer live and pre-submitted questions from the audience covering everything from our product to underlying technologies, industry trends, market dynamics, and our utility token TRL.
_________…
_________…
Fact of the day 🔍
80% of research site staff are somewhat or very optimistic about the future operating environment for clinical trials.
Research site optimism is significantly related to the degree to which site staff feels that sponsors request, value, and apply feedback from the site.
Triall helps promote site engagement and collaboration by offering a single point access solution with intuitive tools for data capture and patient management.
Source: https://csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1622565773569818624?s=20&t=kkCPVJzFhTtR0g1fiHfWOw
#blockchainforhealth #TRL
80% of research site staff are somewhat or very optimistic about the future operating environment for clinical trials.
Research site optimism is significantly related to the degree to which site staff feels that sponsors request, value, and apply feedback from the site.
Triall helps promote site engagement and collaboration by offering a single point access solution with intuitive tools for data capture and patient management.
Source: https://csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1622565773569818624?s=20&t=kkCPVJzFhTtR0g1fiHfWOw
#blockchainforhealth #TRL
Triall featured in Applied Clinical Trials 🗞️
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials Magazine, one of the top journals for clinical operations professionals.
The article covers the current state of patient-centric clinical research, focusing on the areas of convenience, empowerment, and privacy.
It then takes a leap forward by examining how Self-Sovereign Identity (SSI), a novel approach to digital identity and access management, will help advance patient-centric research by enabling patient data ownership.
👉 Article link: https://www.appliedclinicaltrialsonline.com/view/enabling-patient-data-ownership-with-self-sovereign-identity
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1622946925786943488?s=20&t=Pg_M83QhNwRGT1HpituF3w
#blockchainforhealth #TRL
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials Magazine, one of the top journals for clinical operations professionals.
The article covers the current state of patient-centric clinical research, focusing on the areas of convenience, empowerment, and privacy.
It then takes a leap forward by examining how Self-Sovereign Identity (SSI), a novel approach to digital identity and access management, will help advance patient-centric research by enabling patient data ownership.
👉 Article link: https://www.appliedclinicaltrialsonline.com/view/enabling-patient-data-ownership-with-self-sovereign-identity
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1622946925786943488?s=20&t=Pg_M83QhNwRGT1HpituF3w
#blockchainforhealth #TRL
How Triall is using AI 🤖
Electronic health records (EHRs) have long remained underutilised in clinical research.
Manual data entry of EHRs in the clinical trial database can quickly turn into an administrative burden for research sites who are often already short on time.
Our AI module automates this process using Machine Learning. It enables researchers to directly access, structure, and import EHR data into their database, transforming unstructured EHR data into structured EDC data entries.
This removes the need for manual and duplicate data entry, saving significant time and resources, all while reducing the chance of transcription errors.
👉 More info: triall.io/products/ai
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1623658997516578816?s=20&t=dlN8vlmw_A2aGpAA3-aukQ
#blockchainforhealth #TRL
Electronic health records (EHRs) have long remained underutilised in clinical research.
Manual data entry of EHRs in the clinical trial database can quickly turn into an administrative burden for research sites who are often already short on time.
Our AI module automates this process using Machine Learning. It enables researchers to directly access, structure, and import EHR data into their database, transforming unstructured EHR data into structured EDC data entries.
This removes the need for manual and duplicate data entry, saving significant time and resources, all while reducing the chance of transcription errors.
👉 More info: triall.io/products/ai
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1623658997516578816?s=20&t=dlN8vlmw_A2aGpAA3-aukQ
#blockchainforhealth #TRL
Announcing this month’s AMA winners 🏆📺💬
Last week, Triall hosted its 11th monthly community AMA live on YouTube.
Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team.
AMA winner list
@Andromedamin
@Algojali
@Aghaspar10
@sunsun77
@Justice321
How do I redeem my reward?
Please contact @rxvdwaal to share your BEP-20 address.
Missed the live session?
Check out the full recording: https://www.youtube.com/live/VZF5RnCDSbk?feature=share
When is the next AMA?
Gear up for our next AMA, which will focus exclusively on $TRL (date to be announced). Start submitting your questions here: bit.ly/TRLvidAMA12
#blockchainforhealth #TRL
Last week, Triall hosted its 11th monthly community AMA live on YouTube.
Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team.
AMA winner list
@Andromedamin
@Algojali
@Aghaspar10
@sunsun77
@Justice321
How do I redeem my reward?
Please contact @rxvdwaal to share your BEP-20 address.
Missed the live session?
Check out the full recording: https://www.youtube.com/live/VZF5RnCDSbk?feature=share
When is the next AMA?
Gear up for our next AMA, which will focus exclusively on $TRL (date to be announced). Start submitting your questions here: bit.ly/TRLvidAMA12
#blockchainforhealth #TRL
Fact of the day 🔍
Phase 3 clinical trials collect on average 3x more data compared to 10 years ago.
A typical Phase 3 study now collects over 3.6M data points as a result of complex study designs and a higher volume and variety of data sources.
Triall’s end-to-end eClinical platform facilitates proactive study management and oversight by uniting all data streams in a single integrated platform.
Source: https://csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1625077818542497793?s=20&t=MZaJRIbrIheUzX62wiGn9Q
#blockchainforhealth #TRL
Phase 3 clinical trials collect on average 3x more data compared to 10 years ago.
A typical Phase 3 study now collects over 3.6M data points as a result of complex study designs and a higher volume and variety of data sources.
Triall’s end-to-end eClinical platform facilitates proactive study management and oversight by uniting all data streams in a single integrated platform.
Source: https://csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1625077818542497793?s=20&t=MZaJRIbrIheUzX62wiGn9Q
#blockchainforhealth #TRL
Triall token economics explained 🌐
Want to learn more about the role of $TRL in the Triall ecosystem?
We’ve updated our animated explainer video to align with our improved token economics.
The video covers our 4 core principles:
(1) Lock $TRL to access the Triall Platform;
(2) Burn $TRL to access the two-token system;
(3) Increase liquidity of the TRL token market; and
(4) Provide the community with improved insights into active clinical trials and associated token economics.
👉 Check out the new video: youtu.be/FJo7aPlAdXM
Any questions related to $TRL?
Join our next AMA, you can submit your questions here: bit.ly/TRLvidAMA12
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1625123628739178496?s=20&t=nov7qsfkHej_Wqnswn9sZA
#blockchainforhealth #TRL
Want to learn more about the role of $TRL in the Triall ecosystem?
We’ve updated our animated explainer video to align with our improved token economics.
The video covers our 4 core principles:
(1) Lock $TRL to access the Triall Platform;
(2) Burn $TRL to access the two-token system;
(3) Increase liquidity of the TRL token market; and
(4) Provide the community with improved insights into active clinical trials and associated token economics.
👉 Check out the new video: youtu.be/FJo7aPlAdXM
Any questions related to $TRL?
Join our next AMA, you can submit your questions here: bit.ly/TRLvidAMA12
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1625123628739178496?s=20&t=nov7qsfkHej_Wqnswn9sZA
#blockchainforhealth #TRL
YouTube
Triall - Token economics (updated) - Explaining the role of utility tokens TRL and T-CRED
This video explains the role of utility tokens TRL and T-CRED in the Triall ecosystem. Our previous animated explainer video has been updated in accordance with our improved token economics as explained here: https://medium.com/triall/strengthening-the-trl…
Fact of the day 🔍
According to GlobalData, 79% of healthcare professionals have a digital transformation strategy in place or are working towards one.
A growing body of organisations embrace emerging technologies to remain competitive and resilient to changing business conditions.
Triall supports sponsors, CROs, and sites in future-proofing their business by offering a range of eClinical tools for digitalising clinical operations.
Source: globaldata.com/store/report/digital-transformation-and-emerging-technology-in-healthcare-theme-analysis/
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1627636987208376320?s=20
#blockchainforhealth #TRL
According to GlobalData, 79% of healthcare professionals have a digital transformation strategy in place or are working towards one.
A growing body of organisations embrace emerging technologies to remain competitive and resilient to changing business conditions.
Triall supports sponsors, CROs, and sites in future-proofing their business by offering a range of eClinical tools for digitalising clinical operations.
Source: globaldata.com/store/report/digital-transformation-and-emerging-technology-in-healthcare-theme-analysis/
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1627636987208376320?s=20
#blockchainforhealth #TRL
Announcing our next community AMA 📺💬
Questions about $TRL and its token economics?
On February 27 at 15:30 UTC, Triall will host its 12th community AMA on YouTube, focusing exclusively on questions related to $TRL.
🎙 AMA Guests
- Niels Klomp, Chief Technology Officer
- Joost Flach, Head of Operations
- Raymond van der Waal, Head of Strategic Partnerships
📬 AMA Questions
Submit your questions here: bit.ly/TRLvidAMA12
The 5 best questions get $50 in TRL tokens💰
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1627998550322819073?s=20
#blockchainforhealth #TRL
Questions about $TRL and its token economics?
On February 27 at 15:30 UTC, Triall will host its 12th community AMA on YouTube, focusing exclusively on questions related to $TRL.
🎙 AMA Guests
- Niels Klomp, Chief Technology Officer
- Joost Flach, Head of Operations
- Raymond van der Waal, Head of Strategic Partnerships
📬 AMA Questions
Submit your questions here: bit.ly/TRLvidAMA12
The 5 best questions get $50 in TRL tokens💰
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1627998550322819073?s=20
#blockchainforhealth #TRL
Fact of the day 🔍
According to a study by IQVIA, decentralised trials can realise a 54% reduction in protocol deviations.
Protocol deviations can result in patient safety risks, costly protocol amendments, and lengthy trial delays.
Triall offers a range of decentralised trial tools that help clinical research professionals with maintaining protocol compliance throughout all of their core study activities.
Source: bit.ly/3BxPXev
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1630180768386252802?s=20
#blockchainforhealth #TRL
According to a study by IQVIA, decentralised trials can realise a 54% reduction in protocol deviations.
Protocol deviations can result in patient safety risks, costly protocol amendments, and lengthy trial delays.
Triall offers a range of decentralised trial tools that help clinical research professionals with maintaining protocol compliance throughout all of their core study activities.
Source: bit.ly/3BxPXev
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1630180768386252802?s=20
#blockchainforhealth #TRL
And we’re live once again! 🚨📺💬
Tune in to our $TRL-focused Triall community AMA 👇
https://www.youtube.com/watch?v=h5ywT0h65oo
Tune in to our $TRL-focused Triall community AMA 👇
https://www.youtube.com/watch?v=h5ywT0h65oo
YouTube
Triall community AMA #12
In the Triall community AMA, members of the core Triall team answer live and pre-submitted questions from the audience covering everything from our product to underlying technologies, industry trends, market dynamics, and our utility token TRL.
_________…
_________…
New staking pool incoming 💎
We’re excited to share that a new $TRL staking pool will be opening this Saturday, March 4 at 18:00 UTC.
The BSC Holder 7 (8% APR) pool will launch on BSC and runs for 100 days.
Get ready to stake and join other $TRL token holders who've staked more than 10 million TRL since the launch of our token.
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking tech is powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1630904184986894337?s=20
#blockchainforhealth #TRL
We’re excited to share that a new $TRL staking pool will be opening this Saturday, March 4 at 18:00 UTC.
The BSC Holder 7 (8% APR) pool will launch on BSC and runs for 100 days.
Get ready to stake and join other $TRL token holders who've staked more than 10 million TRL since the launch of our token.
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking tech is powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1630904184986894337?s=20
#blockchainforhealth #TRL
New staking pool opening tomorrow 💎
Get ready to stake! A new $TRL staking pool will be opening this Saturday, March 4 at 18:00 UTC.
The BSC Holder 7 (8% APR) pool will launch on BSC and runs for 100 days.
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking tech is powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1631608931234480129?s=20
#blockchainforhealth #TRL
Get ready to stake! A new $TRL staking pool will be opening this Saturday, March 4 at 18:00 UTC.
The BSC Holder 7 (8% APR) pool will launch on BSC and runs for 100 days.
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking tech is powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1631608931234480129?s=20
#blockchainforhealth #TRL
New staking pool is live 💎
Our new $TRL staking pool is now open for staking!
The BSC Holder 7 (8% APR) pool is available on BSC and runs for 100 days.
Join other $TRL token holders who've staked over 10 million TRL since TGE.
👉 Start staking today at triall.io/staking
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking tech is powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1632078457609003008?s=20
#blockchainforhealth #TRL
Our new $TRL staking pool is now open for staking!
The BSC Holder 7 (8% APR) pool is available on BSC and runs for 100 days.
Join other $TRL token holders who've staked over 10 million TRL since TGE.
👉 Start staking today at triall.io/staking
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking tech is powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1632078457609003008?s=20
#blockchainforhealth #TRL
Fact of the day 🔍
According to the IQVIA Institute, 1.8 million people participated in clinical trials across 2022.
The last 4 years have seen record-breaking numbers of participants in clinical research.
Triall offers a single-access platform where clinical trial sponsors, sites, and participants can securely interact and collaborate on key study activities.
Source: iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1632724370064826369?s=20
#blockchainforhealth #TRL
According to the IQVIA Institute, 1.8 million people participated in clinical trials across 2022.
The last 4 years have seen record-breaking numbers of participants in clinical research.
Triall offers a single-access platform where clinical trial sponsors, sites, and participants can securely interact and collaborate on key study activities.
Source: iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1632724370064826369?s=20
#blockchainforhealth #TRL
Announcing the AMA winners 🏆📺💬
Last week, Triall hosted its 12th monthly community AMA live on YouTube.
Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team.
AMA winner list
@neodufour
@xmotions
@Defi58
@Pandalucu66
@Idee01
How do I redeem my reward?
Please contact @rxvdwaal to share your BEP-20 address.
Missed the live session?
Check out the full recording: https://www.youtube.com/live/h5ywT0h65oo?feature=share
When is the next AMA?
Our next community AMA will be hosted by the end of this month (date to be announced).
#blockchainforhealth #TRL
Last week, Triall hosted its 12th monthly community AMA live on YouTube.
Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team.
AMA winner list
@neodufour
@xmotions
@Defi58
@Pandalucu66
@Idee01
How do I redeem my reward?
Please contact @rxvdwaal to share your BEP-20 address.
Missed the live session?
Check out the full recording: https://www.youtube.com/live/h5ywT0h65oo?feature=share
When is the next AMA?
Our next community AMA will be hosted by the end of this month (date to be announced).
#blockchainforhealth #TRL
Fact of the day 🔍
70% of potential clinical trial participants live more than 2 hours away from a research site.
Triall’s software platform offers the latest in decentralised and mobile technologies to promote patient convenience and help sponsors access a larger and more diverse patient pool.
Source: https://mck.co/3a4b396
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1635256640009293824?s=20
#blockchainforhealth #TRL
70% of potential clinical trial participants live more than 2 hours away from a research site.
Triall’s software platform offers the latest in decentralised and mobile technologies to promote patient convenience and help sponsors access a larger and more diverse patient pool.
Source: https://mck.co/3a4b396
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1635256640009293824?s=20
#blockchainforhealth #TRL
In the news: there’s a worrying amount of fraud in medical research 🗞️
According to a recent article published in The Economist, as much as 1 in 50 research papers includes results which are unreliable because of fabrication, plagiarism, or serious errors.
A large amount of these fabricated papers claim to report on clinical trials. Common patterns among fraudulent clinical trial papers include unusually big treatment effects, peculiar participant drop-out rates, or the same data appearing in different trial reports.
Triall aims to make clinical research more reliable and verifiable using blockchain.
Using our blockchain anchoring API, researchers can de-risk the likelihood of data manipulation by making trial-related data, documents, and processes tamper-resistant.
Source: https://www.economist.com/science-and-technology/2023/02/22/there-is-a-worrying-amount-of-fraud-in-medical-research
#blockchainforhealth #TRL
According to a recent article published in The Economist, as much as 1 in 50 research papers includes results which are unreliable because of fabrication, plagiarism, or serious errors.
A large amount of these fabricated papers claim to report on clinical trials. Common patterns among fraudulent clinical trial papers include unusually big treatment effects, peculiar participant drop-out rates, or the same data appearing in different trial reports.
Triall aims to make clinical research more reliable and verifiable using blockchain.
Using our blockchain anchoring API, researchers can de-risk the likelihood of data manipulation by making trial-related data, documents, and processes tamper-resistant.
Source: https://www.economist.com/science-and-technology/2023/02/22/there-is-a-worrying-amount-of-fraud-in-medical-research
#blockchainforhealth #TRL